Skip to main content
SpringerLink
Log in
Book cover

Core Concepts in Dialysis and Continuous Therapies pp 71–91Cite as

Vascular Access in Hemodialysis

  • Chapter
  • First Online:

  • 1797 Accesses

Abstract

Hemodialysis remains the primary modality of renal replacement therapy for patients reaching end-stage renal disease (ESRD). The patient’s vascular access provides the conduit that allows for successful delivery of dialysis therapy. Thus, the vascular access is truly the “lifeline” for the hemodialysis patient. There are three primary types of vascular access a hemodialysis patient can utilize for dialysis therapy: (1) arteriovenous fistula, (2) arteriovenous graft, and (3) tunneled hemodialysis catheter. Each type of vascular access provides distinct advantages and disadvantages. The ideal vascular access would be useable soon after creation with low maturation failure rates and have infrequent mechanical and infectious complications. However, the ideal vascular access does not currently exist. Thus, appropriate vascular access selection, maintenance of vascular access, and development of therapies to treat vascular access dysfunction remain critical to improving morbidity and mortality for hemodialysis patients.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lee T. Novel paradigms for dialysis vascular access: downstream vascular biology-is there a final common pathway? Clin J Am Soc Nephrol. 2013;8:2194–2201.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lee T, Roy-Chaudhury P. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis. 2009;16(5):329–38.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48:S176–273.

    Google Scholar 

  4. Levinsky NG. The organization of medical care. Lessons from the medicare end stage renal disease program. N Engl J Med. 1993;329(19):1395–9.

    Article  CAS  PubMed  Google Scholar 

  5. Rostand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli TE. Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int. 1979;16(5):600–11.

    Article  CAS  PubMed  Google Scholar 

  6. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int. 2002;62(4):1109–24.

    Article  PubMed  Google Scholar 

  7. Port FK. Morbidity and mortality in dialysis patients. Kidney Int. 1994;46(6):1728–37.

    Article  CAS  PubMed  Google Scholar 

  8. Schwab SJ, Harrington JT, Singh A, Roher R, Shohaib SA, Perrone RD, et al. Vascular access for hemodialysis. Kidney Int. 1999;55(5):2078–90.

    Article  CAS  PubMed  Google Scholar 

  9. Schwab SJ, Raymond JR, Saeed M, Newman GE, Dennis PA, Bollinger RR. Prevention of hemodialysis fistula thrombosis. Early detection of venous stenoses. Kidney Int. 1989;36(4):707–11.

    Article  CAS  PubMed  Google Scholar 

  10. Besarab A, Sullivan KL, Ross RP, Moritz MJ. Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis. Kidney Int. 1995;47(5):1364–73.

    Article  CAS  PubMed  Google Scholar 

  11. Safa AA, Valji K, Roberts AC, Ziegler TW, Hye RJ, Oglevie SB. Detection and treatment of dysfunctional hemodialysis access grafts: effect of a surveillance program on graft patency and the incidence of thrombosis. Radiology. 1996;199(3):653–7.

    Article  CAS  PubMed  Google Scholar 

  12. McCarley P, Wingard RL, Shyr Y, Pettus W, Hakim RM, Ikizler TA. Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int. 2001;60(3):1164–72.

    Article  CAS  PubMed  Google Scholar 

  13. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7(4):523–35.

    CAS  PubMed  Google Scholar 

  14. NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-dialysis outcomes quality initiative. Am J Kidney Dis. 1997;30(4 Suppl 3):S150–91.

    Google Scholar 

  15. Fistula First National Access Improvements Initiative. 2014. http://www.fistulafirst.org/. Accessed 3 June 2014.

  16. National Kidney Foundation. DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis. 2001;37(1):137–S81.

    Article  Google Scholar 

  17. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, et al. US Renal Data System 2012 annual data report. Am J Kidney Dis. 2013;61(1 Suppl 1):A7, e1–476.

    Article  Google Scholar 

  18. Lee T, Roy-Chaudhury P, Thakar CV. Improving incident fistula rates: a process of care issue. Am J Kidney Dis. 2011;57(6):814–7.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Allon M, Bailey R, Ballard R, Deierhoi MH, Hamrick K, Oser R, et al. A multidisciplinary approach to hemodialysis access: prospective evaluation. Kidney Int. 1998;53(2):473–9.

    Article  CAS  PubMed  Google Scholar 

  20. Lok CE, Oliver MJ. Overcoming barriers to arteriovenous fistula creation and use. Semin Dial. 2003;16(3):189–96.

    Article  PubMed  Google Scholar 

  21. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299(18):2164–71.

    Article  CAS  PubMed  Google Scholar 

  22. Hodges TC, Fillinger MF, Zwolak RM, Walsh DB, Bech F, Cronenwett JL. Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg. 1997;26(6):1009–19.

    Article  CAS  PubMed  Google Scholar 

  23. Silva MB Jr, Hobson RW 2nd, Pappas PJ, Jamil Z, Araki CT, Goldberg MC, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg. 1998;27(2):302–7. discussion 7–8.

    Article  PubMed  Google Scholar 

  24. Miller PE, Tolwani A, Luscy CP, Deierhoi MH, Bailey R, Redden DT, et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int. 1999;56(1):275–80.

    Article  CAS  PubMed  Google Scholar 

  25. Murphy GJ, White SA, Knight AJ, Doughman T, Nicholson ML. Long-term results of arteriovenous fistulas using transposed autologous basilic vein. Br J Surg. 2000;87(6):819–23.

    Article  CAS  PubMed  Google Scholar 

  26. Revanur VK, Jardine AG, Hamilton DH, Jindal RM. Outcome for arterio-venous fistula at the elbow for haemodialysis. Clin Transpl. 2000;14(4 Pt 1):318–22.

    Article  CAS  Google Scholar 

  27. Wolowczyk L, Williams AJ, Donovan KL, Gibbons CP. The snuffbox arteriovenous fistula for vascular access. Eur J Vasc Endovasc Surg. 2000;19(1):70–6.

    Article  CAS  PubMed  Google Scholar 

  28. Gibson KD, Caps MT, Kohler TR, Hatsukami TS, Gillen DL, Aldassy M, et al. Assessment of a policy to reduce placement of prosthetic hemodialysis access. Kidney Int. 2001;59(6):2335–45.

    Article  CAS  PubMed  Google Scholar 

  29. Allon M, Lockhart ME, Lilly RZ, Gallichio MH, Young CJ, Barker J, et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int. 2001;60(5):2013–20.

    Article  CAS  PubMed  Google Scholar 

  30. Oliver MJ, McCann RL, Indridason OS, Butterly DW, Schwab SJ. Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int. 2001;60(4):1532–9.

    Article  CAS  PubMed  Google Scholar 

  31. Sedlacek M, Teodorescu V, Falk A, Vassalotti JA, Uribarri J. Hemodialysis access placement with preoperative noninvasive vascular mapping: comparison between patients with and without diabetes. Am J Kidney Dis. 2001;38(3):560–4.

    Article  CAS  PubMed  Google Scholar 

  32. Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Dis. 2002;39(1):92–101.

    Article  PubMed  Google Scholar 

  33. Lee T, Ullah A, Allon M, Succop P, El-Khatib M, Munda R, et al. Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol. 2011;6(3):575–81.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Lee T, Barker J, Allon M. Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula. J Am Soc Nephrol. 2007;18(6):1936–41.

    Article  PubMed  Google Scholar 

  35. Kats M, Hawxby AM, Barker J, Allon M. Impact of obesity on arteriovenous fistula outcomes in dialysis patients. Kidney Int. 2007;71(1):39–43.

    Article  CAS  PubMed  Google Scholar 

  36. Vachharajani TJ. Atlas of vascular access. 2014. http://www.fistulafirst.org. Accessed 1 June 2014.

  37. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med. 1966;275(20):1089–92.

    Article  CAS  PubMed  Google Scholar 

  38. Lauvao LS, Ihnat DM, Goshima KR, Chavez L, Gruessner AC, Mills JL Sr. Vein diameter is the major predictor of fistula maturation. J Vasc Surg. 2009;49(6):1499–504.

    Article  PubMed  Google Scholar 

  39. Tordoir JH, Rooyens P, Dammers R, van der Sande FM, de Haan M, Yo TI. Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis. Nephrol Dial Transpl. 2003;18(2):378–83.

    Article  Google Scholar 

  40. Rao RK, Azin GD, Hood DB, Rowe VL, Kohl RD, Katz SG, et al. Basilic vein transposition fistula: a good option for maintaining hemodialysis access site options? J Vasc Surg. 2004;39(5):1043–7.

    Article  PubMed  Google Scholar 

  41. Paulson KA, Gordon V, Flynn L, Lorelli D. Modified two-stage basilic vein transposition for hemodialysis access. Am J Surg. 2011;202(2):184–7.

    Article  PubMed  Google Scholar 

  42. Jennings WC, Sideman MJ, Taubman KE, Broughan TA. Brachial vein transposition arteriovenous fistulas for hemodialysis access. J Vasc Surg. 2009;50(5):1121–5. discussion 5–6.

    Article  PubMed  Google Scholar 

  43. Ramanathan AK, Nader ND, Dryjski ML, Dosluoglu HH, Cherr GS, Curl GR, et al. A retrospective review of basilic and cephalic vein-based fistulas. Vascular. 2011;19(2):97–104.

    Article  PubMed  Google Scholar 

  44. Maya ID, O’Neal JC, Young CJ, Barker-Finkel J, Allon M. Outcomes of brachiocephalic fistulas, transposed brachiobasilic fistulas, and upper arm grafts. Clin J Am Soc Nephrol. 2009;4(1):86–92.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Miller A, Holzenbein TJ, Gottlieb MN, Sacks BA, Lavin PT, Goodman WS, et al. Strategies to increase the use of autogenous arteriovenous fistula in end-stage renal disease. Ann Vasc Surg. 1997;11(4):397–405.

    Article  CAS  PubMed  Google Scholar 

  46. Asif A, Cherla G, Merrill D, Cipleu CD, Tawakol JB, Epstein DL, et al. Venous mapping using venography and the risk of radiocontrast-induced nephropathy. Semin Dial. 2005;18(3):239–42.

    Article  PubMed  Google Scholar 

  47. Roy-Chaudhury P, Arend L, Zhang J, Krishnamoorthy M, Wang Y, Banerjee R, et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis. 2007;50(5):782–90.

    Article  PubMed  Google Scholar 

  48. Roy-Chaudhury P, Wang Y, Krishnamoorthy M, Zhang J, Banerjee R, Munda R, et al. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transpl. 2009;24(9):2786–91.

    Article  CAS  Google Scholar 

  49. Lee T, Wang Y, Arend L, Cornea V, Campos B, Munda R, et al. Comparative analysis of cellular phenotypes within the neointima from vein segments collected prior to vascular access surgery and stenotic arteriovenous dialysis accesses. Semin Dial. 2014;27(3):303–9.

    Article  CAS  PubMed  Google Scholar 

  50. Lee T, Somarathna M, Hura A, Wang Y, Campos B, Arend L, et al. Natural history of venous morphologic changes in dialysis access stenosis. J Vasc Access. 2014;0(0):0.

    Google Scholar 

  51. Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol. 2006;17(4):1112–27.

    Article  PubMed  Google Scholar 

  52. Juncos JP, Grande JP, Kang L, Ackerman AW, Croatt AJ, Katusic ZS, et al. MCP-1 contributes to arteriovenous fistula failure. J Am Soc Nephrol. 2011;22(1):43–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Juncos JP, Tracz MJ, Croatt AJ, Grande JP, Ackerman AW, Katusic ZS, et al. Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse. Kidney Int. 2008;74(1):47–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Misra S, Fu AA, Anderson JL, Sethi S, Glockner JF, McKusick MA, et al. The rat femoral arteriovenous fistula model: increased expression of matrix metalloproteinase-2 and -9 at the venous stenosis. J Vasc Interv Radiol. 2008;19(4):587–94.

    Article  PubMed  Google Scholar 

  55. Haage P, Vorwerk D, Wildberger JE, Piroth W, Schurmann K, Gunther RW. Percutaneous treatment of thrombosed primary arteriovenous hemodialysis access fistulae. Kidney Int. 2000;57(3):1169–75.

    Article  CAS  PubMed  Google Scholar 

  56. Turmel-Rodrigues L, Pengloan J, Baudin S, Testou D, Abaza M, Dahdah G, et al. Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol Dial Transpl. 2000;15(12):2029–36.

    Article  CAS  Google Scholar 

  57. Rajan DK, Clark TW, Simons ME, Kachura JR, Sniderman K. Procedural success and patency after percutaneous treatment of thrombosed autogenous arteriovenous dialysis fistulas. J Vasc Interv Radiol. 2002;13(12):1211–8.

    Article  PubMed  Google Scholar 

  58. Liang HL, Pan HB, Chung HM, Ger LP, Fang HC, Wu TH, et al. Restoration of thrombosed brescia-cimino dialysis fistulas by using percutaneous transluminal angioplasty. Radiology. 2002;223(2):339–44.

    Article  PubMed  Google Scholar 

  59. Shatsky JB, Berns JS, Clark TW, Kwak A, Tuite CM, Shlansky-Goldberg RD, et al. Single-center experience with the Arrow-Trerotola Percutaneous Thrombectomy Device in the management of thrombosed native dialysis fistulas. J Vasc Interv Radiol. 2005;16(12):1605–11.

    Article  PubMed  Google Scholar 

  60. Jain G, Maya ID, Allon M. Outcomes of percutaneous mechanical thrombectomy of arteriovenous fistulas in hemodialysis patients. Semin Dial. 2008;21(6):581–3.

    Article  PubMed  Google Scholar 

  61. Lee T, Tindni A, Roy-Chaudhury P. Improved cumulative survival in fistulas requiring surgical interventions to promote fistula maturation compared with endovascular interventions. Semin Dial. 2013;26(1):85–9.

    Article  PubMed  Google Scholar 

  62. Long B, Brichart N, Lermusiaux P, Turmel-Rodrigues L, Artru B, Boutin JM, et al. Management of perianastomotic stenosis of direct wrist autogenous radial-cephalic arteriovenous accesses for dialysis. J Vasc Surg. 2011;53(1):108–14.

    Article  PubMed  Google Scholar 

  63. Ito Y, Sato T, Okada R, Nakamura N, Kimura K, Takahashi R, et al. Comparison of clinical effectiveness between surgical and endovascular treatment for thrombotic obstruction in hemodialysis access. J Vasc Access. 2011;12(1):63–6.

    Article  PubMed  Google Scholar 

  64. Tessitore N, Mansueto G, Lipari G, Bedogna V, Tardivo S, Baggio E, et al. Endovascular versus surgical preemptive repair of forearm arteriovenous fistula juxta-anastomotic stenosis: analysis of data collected prospectively from 1999 to 2004. Clin J Am Soc Nephrol. 2006;1(3):448–54.

    Article  PubMed  Google Scholar 

  65. Kakkos SK, Andrzejewski T, Haddad JA, Haddad GK, Reddy DJ, Nypaver TJ, et al. Equivalent secondary patency rates of upper extremity vectra vascular access grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment. J Vasc Surg. 2008;47(2):407–14.

    Article  PubMed  Google Scholar 

  66. Allon M. Current management of vascular access. Clin J Am Soc Nephrol. 2007;2(4):786–800.

    Article  PubMed  Google Scholar 

  67. Minga TE, Flanagan KH, Allon M. Clinical consequences of infected arteriovenous grafts in hemodialysis patients. Am J Kidney Dis. 2001;38(5):975–8.

    Article  CAS  PubMed  Google Scholar 

  68. Miller PE, Carlton D, Deierhoi MH, Redden DT, Allon M. Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis. 2000;36(1):68–74.

    Article  CAS  PubMed  Google Scholar 

  69. Miller CD, Robbin ML, Barker J, Allon M. Comparison of arteriovenous grafts in the thigh and upper extremities in hemodialysis patients. J Am Soc Nephrol. 2003;14(11):2942–7.

    Article  PubMed  Google Scholar 

  70. Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int. 1992;42(6):1390–7.

    Article  CAS  PubMed  Google Scholar 

  71. Beathard GA, Marston WA. Endovascular management of thrombosed dialysis access grafts. Am J Kidney Dis. 1998;32(1):172–5.

    Article  CAS  PubMed  Google Scholar 

  72. Beathard GA. Angioplasty for arteriovenous grafts and fistulae. Semin Nephrol. 2002;22(3):202–10.

    Article  PubMed  Google Scholar 

  73. Lilly RZ, Carlton D, Barker J, Saddekni S, Hamrick K, Oser R, et al. Predictors of arteriovenous graft patency after radiologic intervention in hemodialysis patients. Am J Kidney Dis. 2001;37(5):945–53.

    Article  CAS  PubMed  Google Scholar 

  74. Maya ID, Oser R, Saddekni S, Barker J, Allon M. Vascular access stenosis: comparison of arteriovenous grafts and fistulas. Am J Kidney Dis. 2004;44(5):859–65.

    Article  PubMed  Google Scholar 

  75. Beathard GA. Mechanical versus pharmacomechanical thrombolysis for the treatment of thrombosed dialysis access grafts. Kidney Int. 1994;45(5):1401–6.

    Article  CAS  PubMed  Google Scholar 

  76. Beathard GA. Thrombolysis versus surgery for the treatment of thrombosed dialysis access grafts. J Am Soc Nephrol. 1995;6(6):1619–24.

    CAS  PubMed  Google Scholar 

  77. Beathard GA, Welch BR, Maidment HJ. Mechanical thrombolysis for the treatment of thrombosed hemodialysis access grafts. Radiology. 1996;200(3):711–6.

    Article  CAS  PubMed  Google Scholar 

  78. Cohen MA, Kumpe DA, Durham JD, Zwerdlinger SC. Improved treatment of thrombosed hemodialysis access sites with thrombolysis and angioplasty. Kidney Int. 1994;46(5):1375–80.

    Article  CAS  PubMed  Google Scholar 

  79. Trerotola SO, Vesely TM, Lund GB, Soulen MC, Ehrman KO, Cardella JF. Treatment of thrombosed hemodialysis access grafts: Arrow-Trerotola Percutaneous Thrombolytic Device versus pulse-spray thrombolysis. Arrow-Trerotola Percutaneous Thrombolytic Device clinical trial. Radiology. 1998;206(2):403–14.

    Article  CAS  PubMed  Google Scholar 

  80. Trerotola SO, Lund GB, Scheel PJ Jr, Savader SJ, Venbrux AC, Osterman FA. Jr Thrombosed dialysis access grafts: percutaneous mechanical declotting without urokinase. Radiology. 1994;191(3):721–6.

    Article  CAS  PubMed  Google Scholar 

  81. Valji K, Bookstein JJ, Roberts AC, Davis GB. Pharmacomechanical thrombolysis and angioplasty in the management of clotted hemodialysis grafts: early and late clinical results. Radiology. 1991;178(1):243–7.

    Article  CAS  PubMed  Google Scholar 

  82. Kanterman RY, Vesely TM, Pilgram TK, Guy BW, Windus DW, Picus D. Dialysis access grafts: anatomic location of venous stenosis and results of angioplasty. Radiology. 1995;195(1):135–9.

    Article  CAS  PubMed  Google Scholar 

  83. Asif A, Leon C, Orozco-Vargas LC, Krishnamurthy G, Choi KL, Mercado C, et al. Accuracy of physical examination in the detection of arteriovenous fistula stenosis. Clin J Am Soc Nephrol. 2007;2(6):1191–4.

    Article  PubMed  Google Scholar 

  84. Cayco AV, Abu-Alfa AK, Mahnensmith RL, Perazella MA. Reduction in arteriovenous graft impairment: results of a vascular access surveillance protocol. Am J Kidney Dis. 1998;32(2):302–8.

    Article  CAS  PubMed  Google Scholar 

  85. Besarab A, Frinak S, Sherman RA, Goldman J, Dumler F, Devita MV, et al. Simplified measurement of intra-access pressure. J Am Soc Nephrol. 1998;9(2):284–9.

    CAS  PubMed  Google Scholar 

  86. Lumsden AB, MacDonald MJ, Kikeri D, Cotsonis GA, Harker LA, Martin LG. Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. J Vasc Surg. 1997;26(3):382–90. discussion 90–2.

    Article  CAS  PubMed  Google Scholar 

  87. Ram SJ, Work J, Caldito GC, Eason JM, Pervez A, Paulson WD. A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney Int. 2003;64(1):272–80.

    Article  PubMed  Google Scholar 

  88. Moist LM, Churchill DN, House AA, Millward SF, Elliott JE, Kribs SW, et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol. 2003;14(10):2645–53.

    Article  PubMed  Google Scholar 

  89. Dember LM, Holmberg EF, Kaufman JS. Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney Int. 2004;66(1):390–8.

    Article  PubMed  Google Scholar 

  90. Malik J, Slavikova M, Svobodova J, Tuka V. Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney Int. 2005;67(4):1554–8.

    Article  PubMed  Google Scholar 

  91. Robbin ML, Oser RF, Lee JY, Heudebert GR, Mennemeyer ST, Allon M. Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney Int. 2006;69(4):730–5.

    Article  CAS  PubMed  Google Scholar 

  92. Chang CJ, Ko PJ, Hsu LA, Ko YS, Ko YL, Chen CF, et al. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis. 2004;43(1):74–84.

    Article  CAS  PubMed  Google Scholar 

  93. Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001;59(6):2325–34.

    Article  CAS  PubMed  Google Scholar 

  94. Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation. 1989;80(6):1726–36.

    Article  CAS  PubMed  Google Scholar 

  95. Sands JJ, Patel S, Plaviak DJ, Miranda CL. Pharmacomechanical thrombolysis with urokinase for treatment of thrombosed hemodialysis access grafts. A comparison with surgical thrombectomy. Asaio J. 1994;40(3):M886–8.

    Article  CAS  PubMed  Google Scholar 

  96. Maya ID, Allon M. Outcomes of thrombosed arteriovenous grafts: comparison of stents vs angioplasty. Kidney Int. 2006;69(5):934–7.

    Article  CAS  PubMed  Google Scholar 

  97. Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, et al. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 2010;362(6):494–503.

    Article  CAS  PubMed  Google Scholar 

  98. Lacson E Jr, Wang W, Lazarus JM, Hakim RM. Change in vascular access and hospitalization risk in long-term hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(11):1996–2003.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Lacson E Jr, Wang W, Hakim RM, Teng M, Lazarus JM. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access. Am J Kidney Dis. 2009;53(1):79–90.

    Article  CAS  PubMed  Google Scholar 

  100. Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis. 2006;47(3):469–77.

    Article  PubMed  Google Scholar 

  101. Lacson E Jr, Wang W, Lazarus JM, Hakim RM. Change in vascular access and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2009.

    Google Scholar 

  102. Desilva RN, Patibandla BK, Vin Y, Narra A, Chawla V, Brown RS, et al. Fistula first is not always the best strategy for the elderly. J Am Soc Nephrol. 2013;24(8):1297–304.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Wong JK, Sadler DJ, McCarthy M, Saliken JC, So CB, Gray RR. Analysis of early failure of tunneled hemodialysis catheters. AJR Am J Roentgenol. 2002;179(2):357–63.

    Article  CAS  PubMed  Google Scholar 

  104. Liangos O, Gul A, Madias NE, Jaber BL. Long-term management of the tunneled venous catheter. Semin Dial. 2006;19(2):158–64.

    Article  PubMed  Google Scholar 

  105. Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can’t live without them. Kidney Int. 1999;56(1):1–17.

    Article  CAS  PubMed  Google Scholar 

  106. Mokrzycki MH, Lok CE. Traditional and non-traditional strategies to optimize catheter function: go with more flow. Kidney Int. 2010;78(12):1218–31.

    Article  PubMed  Google Scholar 

  107. Hoshal VL Jr, Ause RG, Hoskins PA. Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg. 1971;102(4):353–8.

    Article  PubMed  Google Scholar 

  108. Agraharkar M, Isaacson S, Mendelssohn D, Muralidharan J, Mustata S, Zevallos G, et al. Percutaneously inserted silastic jugular hemodialysis catheters seldom cause jugular vein thrombosis. ASAIO J. 1995;41(2):169–72.

    Article  CAS  PubMed  Google Scholar 

  109. Karnik R, Valentin A, Winkler WB, Donath P, Slany J. Duplex sonographic detection of internal jugular venous thrombosis after removal of central venous catheters. Clin Cardiol. 1993;16(1):26–9.

    Article  CAS  PubMed  Google Scholar 

  110. Beathard GA. Catheter thrombosis. Semin Dial. 2001;14(6):441–5.

    Article  CAS  PubMed  Google Scholar 

  111. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM. Trisodium citrate 4 %—an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transp. 2007;22(2):477–83.

    Article  CAS  Google Scholar 

  112. Negulescu O, Coco M, Croll J, Mokrzycki MH. Large atrial thrombus formation associated with tunneled cuffed hemodialysis catheters. Clin Nephrol. 2003;59(1):40–6.

    Article  CAS  PubMed  Google Scholar 

  113. Buturovic J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P. Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs. 1998;22(11):945–7.

    Article  CAS  PubMed  Google Scholar 

  114. Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, et al. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med. 2011;364(4):303–12.

    Article  CAS  PubMed  Google Scholar 

  115. Forauer AR, Theoharis CG, Dasika NL. Jugular vein catheter placement: histologic features and development of catheter-related (fibrin) sheaths in a swine model. Radiology. 2006;240(2):427–34.

    Article  PubMed  Google Scholar 

  116. Crain MR, Mewissen MW, Ostrowski GJ, Paz-Fumagalli R, Beres RA, Wertz RA. Fibrin sleeve stripping for salvage of failing hemodialysis catheters: technique and initial results. Radiology. 1996;198(1):41–4.

    Article  CAS  PubMed  Google Scholar 

  117. Brady PS, Spence LD, Levitin A, Mickolich CT, Dolmatch BL. Efficacy of percutaneous fibrin sheath stripping in restoring patency of tunneled hemodialysis catheters. AJR Am J Roentgenol. 1999;173(4):1023–7.

    Article  CAS  PubMed  Google Scholar 

  118. Gray RJ, Levitin A, Buck D, Brown LC, Sparling YH, Jablonski KA, et al. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous dialysis catheters: a prospective, randomized trial. J Vasc Interv Radiol. 2000;11(9):1121–9.

    Article  CAS  PubMed  Google Scholar 

  119. Janne d’Othee B, Tham JC, Sheiman RG. Restoration of patency in failing tunneled hemodialysis catheters: a comparison of catheter exchange, exchange and balloon disruption of the fibrin sheath, and femoral stripping. J Vasc Interv Radiol. 2006;17(6):1011–5.

    Article  PubMed  Google Scholar 

  120. Alomari AI, Falk A. The natural history of tunneled hemodialysis catheters removed or exchanged: a single-institution experience. J Vasc Interv Radiol. 2007;18(2):227–35.

    Article  PubMed  Google Scholar 

  121. Onder AM, Chandar J, Coakley S, Francoeur D, Abitbol C, Zilleruelo G. Controlling exit site infections: does it decrease the incidence of catheter-related bacteremia in children on chronic hemodialysis? Hemodial Int. 2009;13(1):11–8.

    Article  PubMed  Google Scholar 

  122. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis. 2004;44(5):779–91.

    Article  PubMed  Google Scholar 

  123. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–22.

    Article  CAS  PubMed  Google Scholar 

  124. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7(2):277–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  125. Lok CE, Mokrzycki MH. Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int. 2011;79(6):587–98.

    Article  CAS  PubMed  Google Scholar 

  126. Tapia G, Yee J. Biofilm: its relevance in kidney disease. Adv Chronic Kidney Dis. 2006;13(3):215–24.

    Article  PubMed  Google Scholar 

  127. Ishizuka M, Nagata H, Takagi K, Kubota K. Comparison of 0.05 % chlorhexidine and 10 % povidone-iodine as cutaneous disinfectant for prevention of central venous catheter-related bloodstream infection: a comparative study. Eur Surg Res (Europaische chirurgische Forschung Recherches chirurgicales europeennes). 2009;43(3):286–90.

    Article  CAS  Google Scholar 

  128. Onder AM, Chandar J, Billings A, Diaz R, Francoeur D, Abitbol C, et al. Chlorhexidine-based antiseptic solutions effectively reduce catheter-related bacteremia. Pediatr Nephrol. 2009;24(9):1741–7.

    Article  PubMed  Google Scholar 

  129. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362(1):18–26.

    Article  CAS  PubMed  Google Scholar 

  130. Paocharoen V, Mingmalairak C, Apisarnthanarak A. Comparison of surgical wound infection after preoperative skin preparation with 4 % chlorhexidine [correction of chlohexidine] and povidone iodine: a prospective randomized trial. J Med Assoc Thai. 2009;92(7):898–902.

    PubMed  Google Scholar 

  131. Valles J, Fernandez I, Alcaraz D, Chacon E, Cazorla A, Canals M, et al. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients. Infect Control Hosp Epidemiol. 2008;29(9):847–53.

    Article  CAS  PubMed  Google Scholar 

  132. Mimoz O, Villeminey S, Ragot S, Dahyot-Fizelier C, Laksiri L, Petitpas F, et al. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care. Arch Intern Med. 2007;167(19):2066–72.

    Article  CAS  PubMed  Google Scholar 

  133. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136(11):792–801.

    Article  CAS  PubMed  Google Scholar 

  134. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol. 2003;14(1):169–79.

    Article  CAS  PubMed  Google Scholar 

  135. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int. 1991;40(5):934–8.

    Article  CAS  PubMed  Google Scholar 

  136. Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol. 1998;9(6):1085–92.

    CAS  PubMed  Google Scholar 

  137. Johnson LB, Jose J, Yousif F, Pawlak J, Saravolatz LD. Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol. 2009;30(1):4–8.

    Article  PubMed  Google Scholar 

  138. Battistella M, Bhola C, Lok CE. Long-term follow-up of the hemodialysis infection prevention with polysporin ointment (HIPPO) study: a quality improvement report. Am J Kidney Dis. 2011;57(3):432–41.

    Article  CAS  PubMed  Google Scholar 

  139. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med. 1986;315(2):91–6.

    Article  CAS  PubMed  Google Scholar 

  140. Boelaert JR, De Smedt RA, De Baere YA, Godard CA, Matthys EG, Schurgers ML, et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transpl. 1989;4(4):278–81.

    CAS  Google Scholar 

  141. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med. 2008;148(8):596–605.

    Article  PubMed  Google Scholar 

  142. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008;47(1):83–93.

    Article  PubMed  Google Scholar 

  143. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis. 2008;51(2):233–41.

    Article  PubMed  Google Scholar 

  144. Snaterse M, Ruger W, Scholte O, Reimer WJ, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect. 2010;75(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  145. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol. 2002;13(8):2133–9.

    Article  CAS  PubMed  Google Scholar 

  146. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis. 2003;36(12):1539–44.

    Article  PubMed  Google Scholar 

  147. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int. 2004;66(2):801–5.

    Article  PubMed  Google Scholar 

  148. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transpl. 2004;19(6):1546–51.

    Article  CAS  Google Scholar 

  149. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, et al. Randomized, clinical trial comparison of trisodium citrate 30 % and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol. 2005;16(9):2769–77.

    Article  CAS  PubMed  Google Scholar 

  150. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int. 2006;69(1):161–4.

    Article  CAS  PubMed  Google Scholar 

  151. Saxena AK, Panhotra BR, Sundaram DS, Morsy MN, Al-Ghamdi AM. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial. Nephrology (Carlton). 2006;11(4):299–305.

    Article  CAS  Google Scholar 

  152. Al-Hwiesh AK, Abdul-Rahman IS. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin. Saudi J Kidney Dis Transpl. 2007;18(2):239–47.

    PubMed  Google Scholar 

  153. Winnett G, Nolan J, Miller M, Ashman N. Trisodium citrate 46.7 % selectively and safely reduces staphylococcal catheter-related bacteraemia. Nephrol Dial Transpl. 2008;23(11):3592–8.

    Article  CAS  Google Scholar 

  154. Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, et al. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis. 2009;53(6):1034–41.

    Article  CAS  PubMed  Google Scholar 

  155. Venditto M, du Montcel ST, Robert J, Trystam D, Dighiero J, Hue D, et al. Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46 % versus heparin/gentamicin. Blood Purif. 2010;29(3):268–73.

    Article  CAS  PubMed  Google Scholar 

  156. Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis. 2012;59(1):102–7.

    Article  CAS  PubMed  Google Scholar 

  157. Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, et al. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis. 2010;55(6):1060–8.

    Article  CAS  PubMed  Google Scholar 

  158. Pervez A, Ahmed M, Ram S, Torres C, Work J, Zaman F, et al. Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J Vasc Access. 2002;3(3):108–13.

    CAS  PubMed  Google Scholar 

  159. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol. 2010;5(10):1799–804.

    Article  PubMed  PubMed Central  Google Scholar 

  160. Stevenson KB, Hannah EL, Lowder CA, Adcox MJ, Davidson RL, Mallea MC, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39(3):549–55.

    Article  PubMed  Google Scholar 

  161. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol. 1999;10(5):1045–9.

    CAS  PubMed  Google Scholar 

  162. Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 2002;61(3):1136–42.

    Article  PubMed  Google Scholar 

  163. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med. 1997;127(4):275–80.

    Article  CAS  PubMed  Google Scholar 

  164. Mokrzycki MH, Schroppel B, von Gersdorff G, Rush H, Zdunek MP, Feingold R. Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus. J Am Soc Nephrol. 2000;11(11):2122–7.

    CAS  PubMed  Google Scholar 

  165. Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transpl. 2004;19(5):1237–44.

    Article  CAS  Google Scholar 

  166. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis. 1999;34(6):1114–24.

    Article  CAS  PubMed  Google Scholar 

  167. Schwab SJ, Weiss MA, Rushton F, Ross JP, Jackson J, Kapoian T, et al. Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int. 2002;62(3):1026–33.

    Article  PubMed  Google Scholar 

  168. Kovalik EC, Raymond JR, Albers FJ, Berkoben M, Butterly DW, Montella B, et al. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection. J Am Soc Nephrol. 1996;7(10):2264–7.

    CAS  PubMed  Google Scholar 

  169. Ashby DR, Power A, Singh S, Choi P, Taube DH, Duncan ND, et al. Bacteremia associated with tunneled hemodialysis catheters: outcome after attempted salvage. Clin J Am Soc Nephrol. 2009;4(10):1601–5.

    Article  PubMed  PubMed Central  Google Scholar 

  170. Capdevila JA, Segarra A, Planes AM, Ramirez-Arellano M, Pahissa A, Piera L, et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transpl. 1993;8(3):231–4.

    CAS  Google Scholar 

  171. Lund GB, Trerotola SO, Scheel PF Jr, Savader SJ, Mitchell SE, Venbrux AC, et al. Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology. 1996;198(2):467–72.

    Article  CAS  PubMed  Google Scholar 

  172. Swartz RD, Messana JM, Boyer CJ, Lunde NM, Weitzel WF, Hartman TL. Successful use of cuffed central venous hemodialysis catheters inserted percutaneously. J Am Soc Nephrol. 1994;4(9):1719–25.

    CAS  PubMed  Google Scholar 

  173. Beathard GA, Settle SM, Shields MW. Salvage of the nonfunctioning arteriovenous fistula. Am J Kidney Dis. 1999;33(5):910–6.

    Article  CAS  PubMed  Google Scholar 

  174. Robinson D, Suhocki P, Schwab SJ. Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int. 1998;53(6):1792–4.

    Article  CAS  PubMed  Google Scholar 

  175. Shaffer D. Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: management by guidewire exchange. Am J Kidney Dis. 1995;25(4):593–6.

    Article  CAS  PubMed  Google Scholar 

  176. Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, et al. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int. 2000;57(5):2151–5.

    Article  CAS  PubMed  Google Scholar 

  177. Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother. 2006;57(6):1172–80.

    Article  CAS  PubMed  Google Scholar 

  178. Vardhan A, Davies J, Daryanani I, Crowe A, McClelland P. Treatment of haemodialysis catheter-related infections. Nephrol Dial Transpl. 2002;17(6):1149–50.

    Article  Google Scholar 

  179. Beathard GA, Litchfield T, Physician Operators Forum of RMS Lifeline Inc. Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists. Kidney Int. 2004;66(4):1622–32.

    Article  PubMed  Google Scholar 

  180. Beathard GA. Gianturco self-expanding stent in the treatment of stenosis in dialysis access grafts. Kidney Int. 1993;43(4):872–7.

    Article  CAS  PubMed  Google Scholar 

  181. Leon C, Asif A. Arteriovenous access and hand pain: the distal hypoperfusion ischemic syndrome. Clin J Am Soc Nephrol. 2007;2(1):175–83.

    Article  PubMed  Google Scholar 

  182. Jackson JW, Lewis JL, Brouillette JR, Brantley RR Jr. Initial experience of a nephrologist-operated vascular access center. Semin Dial. 2000;13(6):354–8.

    Article  CAS  PubMed  Google Scholar 

  183. Jackson J, Litchfield TF. How a dedicated vascular access center can promote increased use of fistulas. Nephrol Nurs J. 2006;33(2):189–96.

    PubMed  Google Scholar 

  184. Asif A, Besarab A, Roy-Chaudhury P, Spergel LM, Ravani P. Interventional nephrology: from episodic to coordinated vascular access care. J Nephrol. 2007;20(4):399–405.

    PubMed  Google Scholar 

  185. Vachharajani TJ, Moossavi S, Salman L, Wu S, Dwyer AC, Ross J, et al. Dialysis vascular access management by interventional nephrology programs at University Medical Centers in the United States. Semin Dial. 2011;24(5):564–9.

    Article  PubMed  Google Scholar 

  186. Vachharajani TJ, Moossavi S, Salman L, Wu S, Maya ID, Yevzlin AS, et al. Successful models of interventional nephrology at academic medical centers. Clin J Am Soc Nephrol. 2010;5(11):2130–6.

    Article  PubMed  Google Scholar 

  187. Beathard GA, Schon D. ASDIN news and update. Semin Dial. 2009;22(3):312–7.

    Article  PubMed  Google Scholar 

  188. American Society of Diagnostic and Interventional Nephrology (ASDIN). http://www.asdin.org. Accessed 7 July 2014.

  189. Sachdeva B, Abreo K. The history of interventional nephrology. Adv Chronic Kidney Dis. 2009;16(5):302–8.

    Article  PubMed  Google Scholar 

  190. Yevzlin A, Asif A. Stent placement in hemodialysis access: historical lessons, the state of the art and future directions. Clin J Am Soc Nephrol. 2009;4(5):996–1008.

    Article  PubMed  Google Scholar 

  191. Inrig JK. Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis. Am J Kidney Dis. 2010;55(3):580–9.

    Article  CAS  PubMed  Google Scholar 

  192. Strippoli GF, Craig JC, Schena FP. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol. 2004;15(2):411–9.

    Article  PubMed  Google Scholar 

  193. Kian K, Asif A. Status of research in vascular access for dialysis. Nephrol Dial Transpl. 2010;25(11):3682–6.

    Article  Google Scholar 

  194. Palmer SC, Sciancalepore M, Strippoli GF. Trial quality in nephrology: how are we measuring up? Am J Kidney Dis. 2011;58(3):335–7.

    Article  PubMed  Google Scholar 

  195. American Society of Nephrology. http://www.asn-online.org/about/committees/committee.aspx?panel=INAG. Accessed 7 July 2014.

  196. Roy-Chaudhury P, Lee TC. Vascular stenosis: biology and interventions. Curr Opin Nephrol Hypertens. 2007;16(6):516–22.

    Article  PubMed  Google Scholar 

  197. Roy-Chaudhury P, Spergel LM, Besarab A, Asif A, Ravani P. Biology of arteriovenous fistula failure. J Nephrol. 2007;20(2):150–63.

    CAS  PubMed  Google Scholar 

  198. Lee T, Chauhan V, Krishnamoorthy M, Wang Y, Arend L, Mistry MJ, et al. Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrol Dial Transpl. 2011;26(7):2264–70.

    Article  Google Scholar 

  199. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM. Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int. 1994;45(5):1477–83.

    Article  CAS  PubMed  Google Scholar 

  200. Schmitz PG, McCloud LK, Reikes ST, Leonard CL, Gellens ME. Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol. 2002;13(1):184–90.

    CAS  PubMed  Google Scholar 

  201. Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med. 2009;360(21):2191–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  202. Lok CE, Moist L, Hemmelgarn BR, Tonelli M, Vazquez MA, Dorval M, et al. Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA. 2012;307(17):1809–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  203. Crowther MA, Clase CM, Margetts PJ, Julian J, Lambert K, Sneath D, et al. Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol. 2002;13(9):2331–7.

    Article  CAS  PubMed  Google Scholar 

  204. Kaufman JS. Antithrombotic agents and the prevention of access thrombosis. Semin Dial. 2000;13(1):40–6.

    Article  CAS  PubMed  Google Scholar 

  205. Dember LM, Imrey PB, Beck GJ, Cheung AK, Himmelfarb J, Huber TS, et al. Objectives and design of the hemodialysis fistula maturation study. Am J Kidney Dis. 2013;63:104–12.

    Article  PubMed  PubMed Central  Google Scholar 

  206. Conte MS, Nugent HM, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson JH. Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. J Vasc Surg. 2009;50(6):1359–68 e1.

    Article  PubMed  Google Scholar 

  207. Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. J Vasc Surg. 2011;54(5):1383–9.

    Article  PubMed  Google Scholar 

  208. Dwivedi AJ, Roy-Chaudhury P, Peden EK, Browne BJ, Ladenheim ED, Scavo VA, et al. Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease. J Vasc Access. 2014;15(5):376–84.

    Article  PubMed  Google Scholar 

  209. Peden EK, Leeser DB, Dixon BS, El-Khatib MT, Roy-Chaudhury P, Lawson JH, et al. A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. J Vasc Access. 2013;14(2):143–51.

    Article  PubMed  Google Scholar 

  210. Hye RJ, Peden EK, O’Connor TP, Browne BJ, Dixon BS, Schanzer AS, et al. Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease. J Vasc Surg. 2014;60(2):454–61.

    Article  PubMed  Google Scholar 

  211. Paulson WD, Kipshidze N, Kipiani K, Beridze N, DeVita MV, Shenoy S, et al. Safety and efficacy of local periadventitial delivery of sirolimus for improving hemodialysis graft patency: first human experience with a sirolimus-eluting collagen membrane (Coll-R). Nephrol Dial Transpl. 2012;27(3):1219–24.

    Article  CAS  Google Scholar 

  212. Chemla E, Tavakoli A, Nikam M, Mitra S, Malete T, Evans J, et al. Arteriovenous fistula creation using the optiflow vascular anastomotic connector: the OPEN (Optiflow PatEncy and MaturatioN) study. J Vasc Access. 2014;15(1):38–44.

    Article  PubMed  Google Scholar 

  213. Lai CC, Fang HC, Mar GY, Liou JC, Tseng CJ, Liu CP. Post-angioplasty far infrared radiation therapy improves 1-year angioplasty-free hemodialysis access patency of recurrent obstructive lesions. Eur J Vasc Endovasc Surg. 2013;46(6):726–32.

    Article  PubMed  Google Scholar 

  214. Lin CC, Chang CF, Lai MY, Chen TW, Lee PC, Yang WC. Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients. J Am Soc Nephrol. 2007;18(3):985–92.

    Article  PubMed  Google Scholar 

  215. Lin CC, Yang WC, Chen MC, Liu WS, Yang CY, Lee PC. Effect of far infrared therapy on arteriovenous fistula maturation: an open-label randomized controlled trial. Am J Kidney Dis. 2013;62(2)304–11.

    Article  PubMed  Google Scholar 

  216. Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther. 2012;19(2):263–72.

    Article  PubMed  Google Scholar 

  217. Moist LM, Lok CE, Vachharajani TJ, Xi W, AlJaishi A, Polkinghorne KR, et al. Optimal hemodialysis vascular access in the elderly patient. Semin Dial. 2012;25(6):640–8.

    Article  PubMed  PubMed Central  Google Scholar 

  218. Vachharajani TJ, Moist LM, Glickman MH, Vazquez MA, Polkinghorne KR, Lok CE, et al. Elderly patients with CKD—dilemmas in dialysis therapy and vascular access. Nat Rev Nephrol. 2014;10(2):116–22.

    Article  CAS  PubMed  Google Scholar 

  219. O’Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18(10):2758–65.

    Article  PubMed  Google Scholar 

  220. O’Donohoe MK, Schwartz LB, Radic ZS, Mikat EM, McCann RL, Hagen PO. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts. Ann Surg. 1991;214(6):727–32.

    Article  PubMed  PubMed Central  Google Scholar 

  221. O’Hare AM. Vascular access for hemodialysis in older adults: a “patient first” approach. J Am Soc Nephrol. 2013;24(8):1187–90.

    Article  PubMed  PubMed Central  Google Scholar 

  222. Reuben DB, Tinetti ME. Goal-oriented patient care—an alternative health outcomes paradigm. N Engl J Med. 2012;366(9):777–9.

    Article  CAS  PubMed  Google Scholar 

  223. Archdeacon P, Shaffer RN, Winkelmayer WC, Falk RJ, Roy-Chaudhury P. Fostering innovation, advancing patient safety: the kidney health initiative. Clin J Am Soc Nephrol. 2013;8(9):1609–17.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Alabama, Birmingham, AL, USA

    Timmy Lee MD, MSPH, FACP, FASN

  2. Department of Nephrology, Memorial Sloan Kettering Center, Birmingham, AL, USA

    MD Roman Shingarev

Authors
  1. Timmy Lee MD, MSPH, FACP, FASN
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MD Roman Shingarev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timmy Lee MD, MSPH, FACP, FASN .

Editor information

Editors and Affiliations

  1. Department of Nephrology, Beaumont Hospital, Dublin, Dublin, Ireland

    Colm C. Magee

  2. Department of Medicine/Renal Division, Brigham and Women's Hospital, BOSTON, Massachusetts, USA

    J. Kevin Tucker

  3. Global and Continuing Education, Harvard Medical School, Boston, Massachusetts, USA

    Ajay K. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Lee, T., Shingarev, R. (2016). Vascular Access in Hemodialysis. In: Magee, C., Tucker, J., Singh, A. (eds) Core Concepts in Dialysis and Continuous Therapies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7657-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7657-4_6

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7655-0

  • Online ISBN: 978-1-4899-7657-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation